Matthew Vincent Dolan, SVP Corporate Strategy-Develop: Dexcom DXCM Sell · Filed 23/03/17

Trade details

Type: Insider sale
Amount: $264,845
Shares · price: 2,303 sh · $115.00 a share
Held after: 33,569 sh
Stock: Dexcom DXCM
Person: Matthew Vincent DolanSVP Corporate Strategy-Develop
Trade date: 23/03/16
Filed: 23/03/17
Days to filing: 1 days

Sold 6.4% of holdings

Share of holding sold: 6.4%

Dexcom trades, last 26 weeks

What else happened in Dexcom around then

Filed or reported within 30 days of the trade day · 23/02/14~23/04/15

Matthew Vincent Dolan's recent trades

Matthew Vincent DolanEVP, Strategy & Corporate Dev
SellDexcom
Sell
Dexcom
DXCM
$102.8K
1,183 sh
$102.8K
Filed 25/01/30
Traded 25/01/29
Matthew Vincent DolanEVP Strategy and Corporate Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$306.7K
2,423 sh
$306.7K
Filed 24/05/16
Traded 24/05/15
Matthew Vincent DolanEVP Strategy and Corporate Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$274.2K
1,990 sh
$274.2K
Filed 24/04/16
Traded 24/04/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$243.6K
1,886 sh
$243.6K
Filed 24/03/19
Traded 24/03/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$171.8K
1,314 sh
$171.8K
Filed 24/03/19
Traded 24/03/15